Dr. David E Marcus, Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1128 Sonoma Ave, Santa Rosa, CA 95405 Phone: 707-575-1626 Fax: 707-575-3941 |
Dr. Roger Philip Friedenthal, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3562 Round Barn Cir Ste 320, Santa Rosa, CA 95403 Phone: 707-578-1900 Fax: 707-578-1111 |
Dr. Harold R. Mancusi-ungaro Jr., MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 Mendocino Ave, Suite 130, Santa Rosa, CA 95403 Phone: 707-566-5288 Fax: 707-566-5471 |
Eric Y. Lin, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 |
Barry Neil Silberg, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1111 Sonoma Ave, Suite 210, Santa Rosa, CA 95405 Phone: 707-528-0911 Fax: 707-528-4602 |
Dr. Kent E Mellerstig, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1043 Slate Dr, Santa Rosa, CA 95405 Phone: 707-527-7211 Fax: 707-538-7044 |
News Archive
Alcohol and impulsivity are a dangerous mix: People with current drinking problems and poor impulse control are more likely to die in the next 15 years, a new study suggests. However, they could get by with a little help from their friends: The study also found that a strong social support network buffers the toxic effects of impulsivity.
In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (EnbrelĀ®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.
Following a request from the Tunisian Government, experts from the UK's Emergency Medical Team (UK EMT), supported by the UK-Public Health Rapid Support Team (UK-PHRST) have arrived in Tunisia today (13 August) to help the country tackle their COVID-19 crisis.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
› Verified 2 days ago